372 related articles for article (PubMed ID: 18930329)
21. Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis.
Lemoine M; Katsahian S; Ziol M; Nahon P; Ganne-Carrie N; Kazemi F; Grando-Lemaire V; Trinchet JC; Beaugrand M
Aliment Pharmacol Ther; 2008 Nov; 28(9):1102-10. PubMed ID: 18691352
[TBL] [Abstract][Full Text] [Related]
22. Impact of liver steatosis on the correlation between liver stiffness and fibrosis measured by transient elastography in patients coinfected with human immunodeficiency virus and hepatitis C virus.
Sánchez-Conde M; Montes Ramírez ML; Bellón Cano JM; Caminoa A; Alvarez Rodríguez F; González Garcia J; Miralles Martín P; Bernardino de la Serna I; Bernardo de Quirós JC; Arribas López JR; Cosín Ochaíta J; Pascual Pareja JF; Alvarez E; Berenguer JB
J Viral Hepat; 2011 Jul; 18(7):e278-83. PubMed ID: 21129129
[TBL] [Abstract][Full Text] [Related]
23. Liver fibrosis: non-invasive assessment with MR elastography.
Huwart L; Peeters F; Sinkus R; Annet L; Salameh N; ter Beek LC; Horsmans Y; Van Beers BE
NMR Biomed; 2006 Apr; 19(2):173-9. PubMed ID: 16521091
[TBL] [Abstract][Full Text] [Related]
24. Non invasive prediction of severe fibrosis in patients with alcoholic liver disease.
Tran A; Hastier P; Barjoan EM; Demuth N; Pradier C; Saint-Paul MC; Guzman-Granier E; Chevallier P; Tran C; Longo F; Schneider S; Piche T; Hebuterne X; Benzaken S; Rampal P
Gastroenterol Clin Biol; 2000; 24(6-7):626-30. PubMed ID: 10962384
[TBL] [Abstract][Full Text] [Related]
25. Serum gamma-glutamyltranspeptidase distinguishes non-alcoholic fatty liver disease at high risk.
Tahan V; Canbakan B; Balci H; Dane F; Akin H; Can G; Hatemi I; Olgac V; Sonsuz A; Ozbay G; Yurdakul I; Senturk H
Hepatogastroenterology; 2008; 55(85):1433-8. PubMed ID: 18795706
[TBL] [Abstract][Full Text] [Related]
26. Clinical factors associated with liver stiffness in hepatitis B e antigen-positive chronic hepatitis B patients.
Wong GL; Wong VW; Choi PC; Chan AW; Chim AM; Yiu KK; Chan HY; Chan FK; Sung JJ; Chan HL
Clin Gastroenterol Hepatol; 2009 Feb; 7(2):227-33. PubMed ID: 19121647
[TBL] [Abstract][Full Text] [Related]
27. Application of transient elastometry to differentiate mild from moderate to severe liver fibrosis in HIV/HCV co-infected patients.
Macías J; Recio E; Vispo E; Rivero A; López-Cortés LF; Ríos MJ; Merino D; González M; Barreiro P; de Lédinghen V; Quereda C; Pineda JA
J Hepatol; 2008 Dec; 49(6):916-22. PubMed ID: 18929426
[TBL] [Abstract][Full Text] [Related]
28. Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease.
Wong VW; Vergniol J; Wong GL; Foucher J; Chan AW; Chermak F; Choi PC; Merrouche W; Chu SH; Pesque S; Chan HL; de Lédinghen V
Am J Gastroenterol; 2012 Dec; 107(12):1862-71. PubMed ID: 23032979
[TBL] [Abstract][Full Text] [Related]
29. Performance of unidimensional transient elastography in staging non-alcoholic steatohepatitis.
Lupsor M; Badea R; Stefanescu H; Grigorescu M; Serban A; Radu C; Crişan D; Sparchez Z; Iancu S; Maniu A
J Gastrointestin Liver Dis; 2010 Mar; 19(1):53-60. PubMed ID: 20361076
[TBL] [Abstract][Full Text] [Related]
30. Steatosis affects the performance of liver stiffness measurement for fibrosis assessment in patients with genotype 1 chronic hepatitis C.
Macaluso FS; Maida M; Cammà C; Cabibbo G; Cabibi D; Alduino R; Di Marco V; Craxì A; Petta S
J Hepatol; 2014 Sep; 61(3):523-9. PubMed ID: 24815874
[TBL] [Abstract][Full Text] [Related]
31. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis.
Friedrich-Rust M; Ong MF; Martens S; Sarrazin C; Bojunga J; Zeuzem S; Herrmann E
Gastroenterology; 2008 Apr; 134(4):960-74. PubMed ID: 18395077
[TBL] [Abstract][Full Text] [Related]
32. Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan(®): validation in chronic hepatitis C.
Sasso M; Tengher-Barna I; Ziol M; Miette V; Fournier C; Sandrin L; Poupon R; Cardoso AC; Marcellin P; Douvin C; de Ledinghen V; Trinchet JC; Beaugrand M
J Viral Hepat; 2012 Apr; 19(4):244-53. PubMed ID: 22404722
[TBL] [Abstract][Full Text] [Related]
33. On-treatment monitoring of liver fibrosis with transient elastography in chronic hepatitis B patients.
Wong GL; Wong VW; Choi PC; Chan AW; Chim AM; Yiu KK; Chu SH; Chan FK; Sung JJ; Chan HL
Antivir Ther; 2011; 16(2):165-72. PubMed ID: 21447865
[TBL] [Abstract][Full Text] [Related]
34. Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography.
Myers RP; Pollett A; Kirsch R; Pomier-Layrargues G; Beaton M; Levstik M; Duarte-Rojo A; Wong D; Crotty P; Elkashab M
Liver Int; 2012 Jul; 32(6):902-10. PubMed ID: 22435761
[TBL] [Abstract][Full Text] [Related]
35. Transient elastography: a valid alternative to biopsy in patients with chronic liver disease.
Gómez-Domínguez E; Mendoza J; Rubio S; Moreno-Monteagudo JA; García-Buey L; Moreno-Otero R
Aliment Pharmacol Ther; 2006 Aug; 24(3):513-8. PubMed ID: 16886917
[TBL] [Abstract][Full Text] [Related]
36. Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values.
Petta S; Wong VW; Cammà C; Hiriart JB; Wong GL; Marra F; Vergniol J; Chan AW; Di Marco V; Merrouche W; Chan HL; Barbara M; Le-Bail B; Arena U; Craxì A; de Ledinghen V
Hepatology; 2017 Apr; 65(4):1145-1155. PubMed ID: 27639088
[TBL] [Abstract][Full Text] [Related]
37. The impact of hepatic steatosis on the natural history of chronic hepatitis C infection.
Cross TJ; Quaglia A; Hughes S; Joshi D; Harrison PM
J Viral Hepat; 2009 Jul; 16(7):492-9. PubMed ID: 19200134
[TBL] [Abstract][Full Text] [Related]
38. Assessment of liver fibrosis by Fibroscan as compared to liver biopsy in biliary atresia.
Shen QL; Chen YJ; Wang ZM; Zhang TC; Pang WB; Shu J; Peng CH
World J Gastroenterol; 2015 Jun; 21(22):6931-6. PubMed ID: 26078570
[TBL] [Abstract][Full Text] [Related]
39. Relationships between fibrosis amounts assessed by morphometry and liver stiffness measurements in chronic hepatitis or steatohepatitis.
Ziol M; Kettaneh A; Ganne-Carrié N; Barget N; Tengher-Barna I; Beaugrand M
Eur J Gastroenterol Hepatol; 2009 Nov; 21(11):1261-8. PubMed ID: 19478678
[TBL] [Abstract][Full Text] [Related]
40. Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases.
Ganne-Carrié N; Ziol M; de Ledinghen V; Douvin C; Marcellin P; Castera L; Dhumeaux D; Trinchet JC; Beaugrand M
Hepatology; 2006 Dec; 44(6):1511-7. PubMed ID: 17133503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
